CHARLES W. NEWHALL III - Director at SUPERNUS PHARMACEUTICALS, INC.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
SUPN on Nasdaq
All Insider Reports
All Insider Reports

CHARLES W. NEWHALL III - trading volume in the past year for SUPERNUS PHARMACEUTICALS, INC.

Holdings reported by CHARLES W. NEWHALL III for SUPERNUS PHARMACEUTICALS, INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 119,644 $1,552,979 $12.98 21 Nov 2025 Direct
Restricted Stock Unit 2,989 $177,658 $39.70 18 Feb 2026 Direct Common Stock
Restricted Stock Units 0 $0 $39.70 22 Feb 2025 Direct Common Stock
Director Stock Option (Right to Buy) 4,977 18 Feb 2026 Direct Common Stock

Transactions reported by CHARLES W. NEWHALL III for SUPERNUS PHARMACEUTICALS, INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.